Completed
Moderated by Eric Lander, with panelists Nancy Andrews, Daniel Fischer, Anna Greka, Kerry Jo Lee, David Meeker, Vamsi Mootha, and Heidi Rehm
Class Central Classrooms beta
YouTube videos curated by Class Central.
Classroom Contents
Ladders to Cures Symposium 2023 - Advances in Rare Disease Research and Therapies
Automatically move to the next video in the Classroom when playback concludes
- 1 Anna Greka,
- 2 Todd Golub,
- 3 Introduced by Heidi Rehm,
- 4 Introduced by Anna Greka,
- 5 Q&A: Elizabeth Engle and Ted Love,
- 6 Chaired by Paul Blainey,
- 7 In silico assessment of druggability of target-disease pairs; Sumaiya Iqbal
- 8 Multiplexed imaging for subcellular interrogation of rare kidney disease; Matt Brown
- 9 Neurobiological insights from human cellular models; Ralda Nehme
- 10 Mechanism of Feature Learning in Neural Networks; Adit Radhakrishnan
- 11 Session 1 Speakers Q&A,
- 12 Introduced by Anahita Vieira
- 13 Q&A: Simon Frost
- 14 Chaired by JT Neal and Jillian Shaw,
- 15 Mitochondrial disorders; Vamsi Mootha
- 16 Two steps forward, one step back: Development of AAV-based gene therapies for congenital myopathies; Alan Beggs
- 17 Large scale CRISPRi-Perturb-seq in endothelial cells identifies shared disease mechanisms between rare and common vascular disorders; Rajat Gupta
- 18 From patients to clinical trials: translational research in neurodevelopmental disorders; Mustafa Sahin
- 19 Session 2 Speakers Q&A,
- 20 Chaired by Anne O’Donnell-Luria and Anthony Philippakis
- 21 Role of biomarkers in rare disease drug development; Eric Minikel
- 22 Building direct-to-patient portals; Clare Bernard and Mounica Yanamandala
- 23 Actionable genetic targets in the era of gene therapies; Tim Yu
- 24 Session 3 Speakers Q&A,
- 25 Introduced by Alex Burgin
- 26 Moderated by Eric Lander, with panelists Nancy Andrews, Daniel Fischer, Anna Greka, Kerry Jo Lee, David Meeker, Vamsi Mootha, and Heidi Rehm
- 27 Closing remarks: Anna Greka
